Introduction
============

During in-season training and after major competitions, the incidence of upper respiratory illness (URI) in athletes, such as cold, sore throat, and others, is increased. The higher incidence of URI in athletes may be associated with exercise-induced changes in stress hormones, such as catecholamine, adrenocorticotropic hormone, and cortisol,[@b1-ijgm-4-837]--[@b3-ijgm-4-837] body temperature changes, dehydration, exercise-induced changes in cellular glutamine metabolism, and lymphocyte apoptosis.[@b2-ijgm-4-837]--[@b5-ijgm-4-837] These modifications result in a decreased organic defense, including lower lymphocyte functionality, proliferation, count, and antibody production, higher neutrophil count, and elevated plasma pro-inflammatory cytokine levels.[@b6-ijgm-4-837]--[@b11-ijgm-4-837]

Nieman et al[@b12-ijgm-4-837] demonstrated a higher incidence of URI in endurance athletes after a major competition or during periods of intense training. Some studies have demonstrated a higher incidence of URI in endurance marathon and ultramarathon runners.[@b13-ijgm-4-837],[@b14-ijgm-4-837] The interactions between exercise, the immune system, and susceptibility to URI have been studied inside the sport context, mainly in endurance exercise.[@b8-ijgm-4-837]--[@b11-ijgm-4-837],[@b14-ijgm-4-837],[@b15-ijgm-4-837] However, there are few studies analyzing the immune response in team sports with intermittent action, such as volleyball, basketball, and handball, during training and competitive periods.[@b16-ijgm-4-837]--[@b18-ijgm-4-837]

Córdova et al[@b1-ijgm-4-837] studied the chronic effects of training and competition during a 4-month season on the immune response of professional volleyball players. The study showed higher immunoglobulin concentration and lymphocyte count after a seasonal training period. In contrast, another study showed no significant changes in interleukin (IL)-6 and tumor necrosis factor (TNF)-α in volleyball athletes during 1 month of increasing training load.[@b19-ijgm-4-837]

The high training intensity can promote a greater release of stress-associated hormones, such as catecholamines and cortisol, which modulate the immune system.[@b10-ijgm-4-837],[@b15-ijgm-4-837] In addition, there is a correlation between pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) with the activation of the hypothalamic-pituitary-adrenal axis and the inhibition of the hypothalamic-pituitary-gonadal axis.[@b20-ijgm-4-837] This highlights the correlation between cytokines and neuroimmunoendocrine and metabolic modulation. Higher serum pro-inflammatory cytokine levels, mainly IL-6 and TNF-α, have been observed after marathon running[@b9-ijgm-4-837],[@b10-ijgm-4-837],[@b15-ijgm-4-837] and have been correlated with increased incidences of URI as a result of excessive training loads and competition. In this sense, high levels of pro-inflammatory cytokines can represent a catabolic milieu inducing a higher incidence of URI.[@b8-ijgm-4-837]

The control of immunological alterations becomes important during in-season training, as a result of the increased incidence of infectious diseases, and may assist in avoiding interruptions in training due to illness. Thus, the magnitude and duration of immunological changes during a season of training for volleyball needs to be clarified.

In view of the abovementioned concerns, the present study aimed to evaluate chronic immune modulations in female volleyball athletes undergoing a competitive period, by the analysis of total and individual leukocyte count, and IL-2, IL-6, and TNF-α plasma levels. Additionally, these variables were correlated with URI symptoms and training-load indicators.

Methods
=======

Subjects
--------

Professional female players (n = 12) from the Piracicabana Association of Volleyball, affiliated to the Paulista Federation of Volleyball; participated during the regular season of competition in the Paulista league (age 19.47 ± 2.49 years; height 1.78 ± 0.08 m, body mass 66.77 ± 7.8 kg, body fat percentage 18.96% ± 2.86%, lean body mass 53.98 ± 5.38 kg, and fat mass 12.78 ± 2.99 kg). Body fat percentage was estimated according to the equation of Jackson et al.[@b21-ijgm-4-837] Volunteers were informed of all the risks before the investigation and signed an informed consent document. The present research was approved by the Research Ethics Committee of the Methodist University of Piracicaba (protocol no. 02/06) and is in accordance with the legal requirements of the Declaration of Helsinki.

Competitive period
------------------

Training periodization was composed of four periods: preparatory (7 weeks); pre-competitive (5 weeks); competitive I (8 weeks), and competitive II (20 weeks). Individuals performed two 3-hour training sessions per day (morning and night), 5 days per week. The main differences between these training periods are associated with load content applied in each period, whereas competitive exercises present in the competitive periods exert an important effect on tiredness, resulting from a higher intensity of muscle action in this type of exercise as compared with general and special exercises. Additionally, competitive exercises produce a higher psychological stress in athletes ([Table 1](#t1-ijgm-4-837){ref-type="table"}).[@b22-ijgm-4-837]

The timing of the evaluations was as follows. Diagnostic evaluations included: anthropometry and immune variables in May (ending of the pre-competitive period and initiation of the competitive I period; fall season, M1). Summative evaluations included: immune variables in July (ending of the competitive I period and initiation of competitive II; winter season, M2) and December (end of the competitive II period; end of spring season, M3). Formative evaluations included: training loads and tiredness subjective scale toward training sessions and competitions; weekly incidence of infection episodes. Data collection (P0) is shown in [Figure 1](#f1-ijgm-4-837){ref-type="fig"}.

Analysis of training load indicators
------------------------------------

Subjective perception of tiredness (SPT) was defined by the rating of perceived exertion of each athlete before and after sessions or games as based on the effort scale by Borg,[@b23-ijgm-4-837] adapted for tiredness. After each training session the duration in minutes was recorded and was defined as the training volume. In addition to this procedure, the scale of subjective perception of intensity proposed by Foster[@b22-ijgm-4-837] was presented to the athletes to calculate the load of each session. The participant was addressed the following question: "What was the intensity of the training in regard to the scale?" The daily training load is defined as the relationship between effort quality (intensity) and volume of training. Thus, training-load indicators were obtained according to Foster.[@b22-ijgm-4-837] Daily load (DL) = SPT × daily session training duration in minutes; mean weekly load (MWL), sum of DL, and total weekly load (TWL = sum of DL/number of training days) were determined in arbitrary units[@b22-ijgm-4-837] ([Table 2](#t2-ijgm-4-837){ref-type="table"}). SPT was evaluated initially (SPTI) and at the end (SPTF) of court sessions.[@b23-ijgm-4-837]

Symptoms of URI
---------------

The incidence of URI symptoms was recorded weekly during the entire period of the study. At the beginning of each training week, athletes were asked about the incidence of URI symptoms. After that, the number of symptoms was recorded. The URIs were defined by symptoms of runny nose, cold, otitis, headache, sore throat, fever, and other symptoms for at least two consecutive days as described by Tsai et al.[@b24-ijgm-4-837] The evaluation of URI symptoms was performed weekly due to the difference between competitive periods and training weeks.

Analysis of immune cells and cytokines
--------------------------------------

Blood draws were performed at rest (24 hours after the last training session), and 8 hours fasting; between 8 am and 9 am in the morning. Immediately after the draw, hematocrit and total and individual leukocytes count were measured, and plasma was stored at −70°C for cytokine determination. A capillary tube was filled to approximately 75% capacity and centrifuged for 5 minutes, while a reading card was used for hematocrit determination; results were expressed by the relative number of cells (%).

The count of total leukocytes was accomplished with 10 μL of blood by adding 190 μL of Turkey liquid (Sigma, St Louis, MO) in an eppendorf, homogenized, and the count was performed in a Neubauer chamber. The circulating levels of neutrophils, lymphocytes, monocytes, eosinophils, and basophils were measured under an optical microscope using a blood smear stained with Giemsa-May Grünwald (Sigma). The analyses were performed on an optical microscope. Results were expressed as number of cells per mm^3^.

Measurements of IL-2, IL-6, and TNF-α in plasma were made by Enzyme-linked immunosorbent assay using the R&D Systems Quantitative High Sensitivity kit (R&D Systems, Minneapolis, MN) for each cytokine in duplicate. The intra-assay coefficient of variance (CV) was 3.2%--10.0%, the inter-assay CV was 4.5%--9.0%, and the sensitivity was 0.0083 pg/mL. Minimal levels detected for IL-2, IL-6, and TNF-α were 10.13, 1.09, and 4.57 pg/mL, respectively.

Statistical analyses
--------------------

The statistical analysis was initially evaluated by the Shapiro--Wilk normality test and by the homoscedasticity test (Bartlett criterion). Since all variables presented a normal distribution and homoscedasticity, a repeated-measures analysis of variance was used, and when the difference was significant, the Tukey post-hoc test for multiple comparisons was applied. Pearson's correlation test was used to determine possible correlations between the analyzed variables. In all calculations, a critical level of *P* ≤ 0.05 was fixed. Results were expressed by mean ± standard error of the mean. The software package used was Statistica (v 6.1; Stat Soft Inc, Tulsa, OK).

Results
=======

Training variables
------------------

There was a statistically significant difference in training-load variables between the different training phases. Total load and total weekly load were higher in M3 as compared with M1 and M2 (*P* \< 0.05). Conversely, mean weekly load was lower in M3 as compared with M1 and M3 (*P* \< 0.05) ([Table 2](#t2-ijgm-4-837){ref-type="table"}). However, there was no statistically significant difference in SPTI and SPTF between training periods.

Blood analysis
--------------

There was no statistically significant alteration in hematocrit. Results revealed a significant increase in total leukocytes in the M2 (*P* \< 0.01) and M3 (*P* \< 0.01) competitive periods compared with M1. Lobulated neutrophils were significantly higher in M2 (*P* \< 0.001) and M3 (*P* \< 0.05) as compared with M1. The same results were observed for total neutrophils, monocytes, and neutrophils/lymphocytes (*P* \< 0.05) ([Table 3](#t3-ijgm-4-837){ref-type="table"}).

In contrast, there was a significant decrease in total lymphocyte count in M3 when compared with M1 (*P* \< 0.05) and M2 (*P* \< 0.001). Basophils, eosinophils, and hematocrit presented no statistically significant difference when compared at all training periods. The measures of IL-2, IL-6, and TNF-α did not change ([Table 3](#t3-ijgm-4-837){ref-type="table"}).

Symptoms of URI
---------------

Symptoms of upper respiratory tract infections increased as the training season progressed. There was a higher incidence of symptoms in M2 (*P* \< 0.001) and M3 (*P* \< 0.01) as compared with M1. There was a higher incidence of runny nose and cold during the training season (*P* \< 0.05; [Table 4](#t4-ijgm-4-837){ref-type="table"}).

On the other hand, sore throat was significantly higher in M2 and M3 compared with M1. Moreover, there was a lower incidence of sore throat symptoms in M2 compared with M3, although this difference was not statistically significant. There was no difference in fever and other symptoms between the training periods ([Table 4](#t4-ijgm-4-837){ref-type="table"}). There was a positive correlation between total leukocytes and training load parameters (0.73) in M2. Similarly, neutrophil count presented a significant correlation with TWL (0.71) and SPTF (0.67) in M2. Moreover, there was a negative correlation between lymphocytes and MWL in the M2 training period (−0.62) ([Table 5](#t5-ijgm-4-837){ref-type="table"}). At the end of the M3 training period, there was a positive correlation between IL-6 levels and SPTF (0.71) ([Table 5](#t5-ijgm-4-837){ref-type="table"}).

Symptoms of upper respiratory tract infections also presented correlations with training load. There was a positive correlation between total symptoms and TWL (0.78), SPTI (0.80), and SPTF (0.90) in M2 and M3 training periods. Runny nose was positively correlated with TWL (0.60), SPTI (0.63), and SPTF (0.79) at the end of the M2 training period, and SPTF (0.74) at the end of M3 ([Table 6](#t6-ijgm-4-837){ref-type="table"}).

The same positive correlation was observed for cold symptoms and TWL (0.60), SPTI (0.65), SPTF (0.79) in M2. However, at the end of the M3 training period, there was a positive correlation between cold, SPTI (0.78), and SPTF (0.85). Sore throat also presented a significant correlation with TWL (0.74), SPTI (0.67), and SPTF (0.74) in M2 ([Table 6](#t6-ijgm-4-837){ref-type="table"}).

Discussion
==========

The purpose of the present study was to evaluate chronic modulations on immune variables in female volleyball athletes, undergoing a competitive period. Another objective was to investigate the correlation between URI symptoms and training-load indicators. Results revealed a higher incidence of symptoms of upper respiratory tract infections in both competitive periods. Moreover, there was an increase in the leukocyte count and IL-2, while no modification in IL-6 and TNF-α was observed.

The results from this study suggest that some aspects of the immune function are modulated by training intensity and volume, which may have implications on URI incidence in athletes. Moreover, the total number of symptoms increased from the M1 to M2 training periods. Thus, illness during a competitive period can represent a suppression of some immune variables, increasing the risk of URI.[@b25-ijgm-4-837] This result can be associated with a higher training volume, as well as higher training intensity. These results were not observed when M2 and M3 were compared. Regarding modulation of the immune system by exercise, few studies have demonstrated the responses in team sports during a season of training.[@b1-ijgm-4-837],[@b16-ijgm-4-837]--[@b18-ijgm-4-837]

Immune modulations, such as elevation of neutrophils and decrease in lymphocytes have been found in football players;[@b1-ijgm-4-837] increased total leukocytes, monocytes, and neutrophils, with no modification in eosinophils and lymphocytes have been found in soccer players[@b18-ijgm-4-837]; and an increase in total leukocytes, monocytes, neutrophils, eosinophils, and lymphocytes has been found in basketball players.[@b16-ijgm-4-837] Although lymphocytes present distinct responses (decrease, increase, or no alteration), total leukocytes and neutrophils seem to show a more similar pattern of increase towards a training season.[@b16-ijgm-4-837],[@b17-ijgm-4-837] The present study revealed an increase in total leukocyte, neutrophil, and monocyte counts, while lymphocytes decreased by the end of the season. The increase observed in lobulated neutrophils, segmented neutrophils, total neutrophils, and monocytes can be associated with muscle tissue remodelation, due to possible damage caused by training load and competition.

Furthermore, we can speculate that the higher training volume and intensity modulated the immune system, increasing the risk of immunosuppression and URI.[@b10-ijgm-4-837],[@b14-ijgm-4-837] The correlation between leukocyte number and higher incidence of URI shows the influence of a competitive period and training-load application, highlighting that the manipulation of training load can modulate the immune system. These modifications can be associated with the accumulated training load and competitions, as well as the individual immune response of each athlete in daily situations, such as psychology stress and food intake.

In contrast, Córdova et al[@b1-ijgm-4-837] demonstrated that during a 4-month volleyball season, immunoglobulin concentrations and lymphocyte count increased in elite men. These modifications can be interpreted as enhanced immunity.[@b26-ijgm-4-837] Interestingly, there was a positive correlation between all symptoms of upper respiratory tract infection and total weekly training load, SPTI, and SPTF. Thus, it can be speculated that both training-load parameters must be controlled to avoid training interruption due to illness.

Regarding cytokines, Masatoshi et al[@b19-ijgm-4-837] showed no significant change in IL-6 and TNF-α pro-inflammatory cytokines in female volleyball players during 1 month with increasing training load. In the present study, the same responses were found at the end of M2 and M3 when compared with the M1 training period. These findings are in contrast to the increases found in serum cytokines after endurance exercise, such as a marathon[@b9-ijgm-4-837],[@b15-ijgm-4-837],[@b27-ijgm-4-837] or prolonged treadmill tests.[@b10-ijgm-4-837],[@b27-ijgm-4-837]

The discrepancy in IL-6 and TNF-α in endurance athletes may be related with the time of blood draw, since runners were evaluated immediately after the race,[@b9-ijgm-4-837],[@b10-ijgm-4-837],[@b15-ijgm-4-837] characterizing an acute response. Furthermore, IL-6 exerts an important metabolic role by regulating fat and glucose metabolism during the continuum of exhaustive exercise.[@b28-ijgm-4-837] Thus, possibly as a result of the intermittent nature of volleyball and other collective sports, cytokines exhibit a different pattern.

Considering that training load can be associated with environmental and psychological aspects, as well as the modulation induced by exercise, stress, and the neuroendocrine system,[@b15-ijgm-4-837],[@b29-ijgm-4-837] the increase in training load and competitions may be an important aspect that contributes to a decrease in the immune response.

Furthermore, the hormone cortisol exerts an important action on leukocyte mobilization, specifically by increasing blood neutrophils.[@b10-ijgm-4-837] In this sense, cortisol and pro-inflammatory cytokines could promote the recruitment of cells from bone marrow.

There was an increase in innate immune cells (specifically monocytes and neutrophils), and a decrease in adaptive immune cells (total lymphocytes) and higher incidence of upper respiratory tract infections from the M1 to M2 training periods. These immune modulations can be associated with the proportional decrease of general exercises and an increase of special exercises, mainly competitive exercises, specific to the sport of volleyball. Moreover, the alterations in innate immunity, adaptive immunity, and the higher incidence of URI can be associated with an increase of the physical and tactical component during the M2 and M3 training periods.

Bury et al[@b17-ijgm-4-837] found a higher incidence of URI in football players than controls, with 77% of the cases taking place during winter. Similarly, there was an increase in URI symptoms in winter months, which were maintained at the end of spring, overlapping with the end of the season. URI symptoms in athletes may be related with seasonality and the accumulated effect of training loads. This observation is based in the positive correlations between neutrophils and training-load indicators at the end of the competitive I period (M2); and mainly by the positive correlations between URI symptoms and training-load indicators during all evaluations. Additionally, the increase in the percentage of competitive exercises and specific physical and tactical training components coincided with higher URI incidence.

Considering that monocytes, basophils, and eosinophils exhibited normal values as compared with reference values towards the evaluation periods, and that lymphocytes were above reference values in M1 and M2 but returned to normal values at the end of the season (M3), and cytokines were unchanged, from the immune point of view, there was an adaptation to training loads and competitions.

IL-2 synthesis by lymphocytes is considered to be an important determinant for protection against infections.[@b10-ijgm-4-837] Thus, the tendency of IL-2 to increase, associated with lymphocyte count, suggests a positive immune status to prevent URI symptoms. Despite the positive correlations between cell count and cytokines with URI at the end of the season, there was a longer period between M2 and M3. This issue can generate a misunderstanding of the immune status with the real mean URI symptoms in this period.

The present study was not designed to study the effect of diet consumption on the immune system during a training season. Therefore, diet consumption was not monitored, which can be considered a study limitation. Additionally, there was no control group and this limitation should be considered. Furthermore, more periodic evaluations, automated cell counting, and the measuring of cell-function parameters (apoptosis and cytotoxicity) should be performed.

In summary, the present study suggests that immune variables, such as total leukocytes, neutrophils, and lymphocytes, can be modulated by training loads, mainly by tactical and physical components. Furthermore, a higher incidence of URI symptoms was correlated with immune cell count, demonstrating that training load and training components are important variables to be controlled. Thus, coaches should prevent negative immunological alterations associated with training load during in-season training and competition. However, there are few investigations relating to the immune system, training load, and seasonal training in volleyball players. Thus, the accumulated effect of sport-specific training loads on chronic immune modulations warrants further investigation.
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![Evaluations toward training periods and competitions.\
**Abbreviation:** URTI, upper respiratory tract infection.](ijgm-4-837f1){#f1-ijgm-4-837}

###### 

The percentage distribution of exercise types performed during periodization

                      M1      M2      M3
  ------------------- ------- ------- -------
  Type of exercises                   
    General           53.45   46.31   47.08
    Special           35.99   40.12   34.42
    Competitive       10.56   13.57   18.5
  Components                          
    Physical          43.82   35.17   41.06
    Technical         19.31   17.48   16.70
    Competitive       36.87   47.34   42.24

**Abbreviations:** M1, pre-competitive period; M2, competitive I period; M3, competitive II period.

###### 

Training variables monitored during the competitive periods

         M1                  M2                  M3
  ------ ------------------- ------------------- ---------------------------------------------------------------------------------------------------------
  TL     7845.37 ± 238.16    5567.75 ± 175       11568.78 ± 425.17[a](#tfn3-ijgm-4-837){ref-type="table-fn"},[b](#tfn4-ijgm-4-837){ref-type="table-fn"}
  MWL    474.34 ± 19.89      466.26 ± 24.77      410.40 ± 10.76[a](#tfn3-ijgm-4-837){ref-type="table-fn"},[b](#tfn4-ijgm-4-837){ref-type="table-fn"}
  TWL    19456.13 ± 715.21   16393.08 ± 641.44   33023.67 ± 1555.95[a](#tfn3-ijgm-4-837){ref-type="table-fn"},[b](#tfn4-ijgm-4-837){ref-type="table-fn"}
  SPTI   10.41 ± 0.11        11.02 ± 0.22        11.36 ± 0.14
  SPTF   12.06 ± 0.21        12.26 ± 0.24        12.95 ± 0.24

**Notes:** Values are presented as mean ± standard deviation;

M2 and M3 are significantly different from M1;

M3 significantly different from M2; *P* ≤ 0.05.

**Abbreviations:** TL, total load; MWL, mean weekly load; TWL, total weekly load; SPTI, subjective perception of tiredness evaluated before court sessions; SPTF, subjective perception of tiredness evaluated at the end of court sessions; M1, pre-competitive period; M2, competitive I period; M3, competitive II period.

###### 

Hematocrit, total and individual leukocytes count, and plasma cytokine levels during periods of evaluation in volleyball athletes (n = 12)

  Blood variables                        M1                  M2                                                           M3
  -------------------------------------- ------------------- ------------------------------------------------------------ -------------------------------------------------------------------------------------------------------
  Hematocrit, %                          38.58 ± 0.64        39.67 ± 0.75                                                 38.89 ± 1.040
  Total leukocytes, cells/mm^3^          11616.67 ± 433.77   13650.00 ± 150.0[a](#tfn7-ijgm-4-837){ref-type="table-fn"}   13666.67 ± 578.31[a](#tfn7-ijgm-4-837){ref-type="table-fn"}
  Neutrophils lobulated, cells/mm^3^     906.17 ± 137.59     1148.50 ± 112.26                                             1644.22 ± 78.84[a](#tfn7-ijgm-4-837){ref-type="table-fn"},[b](#tfn8-ijgm-4-837){ref-type="table-fn"}
  Neutrophils segmented, cells/mm^3^     4805.25 ± 334.97    5384.33 ± 317.81                                             6712.11 ± 466.18[a](#tfn7-ijgm-4-837){ref-type="table-fn"}
  Total neutrophils, cells/mm^3^         5711.42 ± 413.18    6532.83 ± 388.03                                             8356.33 ± 421.55[a](#tfn7-ijgm-4-837){ref-type="table-fn"},[b](#tfn8-ijgm-4-837){ref-type="table-fn"}
  Monocytes, cells/mm^3^                 549.25 ± 48.72      968.17 ± 71.24[a](#tfn7-ijgm-4-837){ref-type="table-fn"}     1181.22 ± 102.40[a](#tfn7-ijgm-4-837){ref-type="table-fn"}
  Basophils, cells/mm^3^                 16.00 ± 12.20       17.17 ± 8.97                                                 47.44 ± 16.24
  Eosinophils, cells/mm^3^               30.25 ± 9.22        74.25 ± 15.96[a](#tfn7-ijgm-4-837){ref-type="table-fn"}      36.67 ± 11.69
  Total lymphocytes, cells/mm^3^         5309.75 ± 306.35    6057.58 ± 322.76                                             4045.00 ± 198.42[a](#tfn7-ijgm-4-837){ref-type="table-fn"},[b](#tfn8-ijgm-4-837){ref-type="table-fn"}
  Neutrophils/lymphocytes, cells/mm^3^   1.14 ± 0.14         1.16 ± 0.15                                                  2.10 ± 0.14[a](#tfn7-ijgm-4-837){ref-type="table-fn"},[b](#tfn8-ijgm-4-837){ref-type="table-fn"}
  IL-2, pg/mL                            1.67 ± 0.39         1.71 ± 0.45                                                  1.65 ± 0.37
  IL-6, pg/mL                            1.78 ± 0.25         2.04 ± 0.13                                                  2.30 ± 0.15
  TNF-α, pg/mL                           1.13 ± 0.62         1.04 ± 0.30                                                  1.03 ± 0.27

**Notes:** Values are presented as mean ± standard error of the mean;

M2 and M3 significantly different from M1;

M3 significantly different from M2; *P* ≤ 0.05.

**Abbreviations:** IL, interleukin; TNF, tumor necrosis factor; M1, pre-competitive period; M2, competitive I period; M3, competitive II period.

###### 

Symptoms of URTI during the periods of evaluation in volleyball athletes (n = 12)

  URTI symptoms    M1            M2                                                       M3
  ---------------- ------------- -------------------------------------------------------- --------------------------------------------------------
  Runny nose       0.04 ± 0.02   0.21 ± 0.05[a](#tfn11-ijgm-4-837){ref-type="table-fn"}   0.21 ± 0.03[a](#tfn11-ijgm-4-837){ref-type="table-fn"}
  Cold             0.02 ± 0.01   0.15 ± 0.04[a](#tfn11-ijgm-4-837){ref-type="table-fn"}   0.19 ± 0.03[a](#tfn11-ijgm-4-837){ref-type="table-fn"}
  Sore throat      0.03 ± 0.02   0.27 ± 0.07[a](#tfn11-ijgm-4-837){ref-type="table-fn"}   0.16 ± 0.03[a](#tfn11-ijgm-4-837){ref-type="table-fn"}
  Fever            0.01 ± 0.01   0.07 ± 0.04                                              0.03 ± 0.02
  Others           0.00 ± 0.00   0.01 ± 0.01                                              0.00 ± 0.00
  Total symptoms   0.10 ± 0.04   0.74 ± 0.15[a](#tfn11-ijgm-4-837){ref-type="table-fn"}   0.60 ± 0.08[a](#tfn11-ijgm-4-837){ref-type="table-fn"}

**Notes:** Values are presented as mean ± standard error of the mean;

M2 and M3 significantly different from M1; *P* ≤ 0.05.

**Abbreviations:** M1, pre-competitive period; M2, competitive I period; M3, competitive II period; URTI, upper respiratory tract infection.

###### 

Pearson's correlations for leukocytes, cytokines, and training-load indicators

  Intervenient factors      M1   M2                                                 M3
  ------------------------- ---- -------------------------------------------------- -------------------------------------------------
  Total leukocytes × TL          0.73[a](#tfn14-ijgm-4-837){ref-type="table-fn"}    0.17
  Total leukocytes × MWL    --   −0.10                                              0.24
  Total leukocytes × TWL    --   0.44                                               0.31
  Total leukocytes × SPTI   --   0.51                                               −0.21
  Total leukocytes × SPTF   --   0.57                                               0.35
  Neutrophils × TL          --   0.42                                               0.13
  Neutrophils × MWL         --   0.55                                               0.37
  Neutrophils × TWL         --   0.71[a](#tfn14-ijgm-4-837){ref-type="table-fn"}    0.44
  Neutrophils × SPTI        --   0.51                                               −0.10
  Neutrophils × SPTF        --   0.67[a](#tfn14-ijgm-4-837){ref-type="table-fn"}    0.55
  Lymphocytes × TL          --   −0.21                                              −0.05
  Lymphocytes × MWL         --   −0.62[a](#tfn14-ijgm-4-837){ref-type="table-fn"}   −0.30
  Lymphocytes × TWL         --   −0.55                                              −0.33
  Lymphocytes × SPTI        --   −0.31                                              −0.38
  Lymphocytes × SPTF        --   −0.46                                              −0.24
  IL-6 × TL                 --   0.49                                               0.24
  IL-6 × MWL                --   0.17                                               0.35
  IL-6 × TWL                --   0.46                                               0.45
  IL-6 × SPTI               --   0.24                                               0.20
  IL-6 × SPTF               --   0.41                                               0.71[a](#tfn14-ijgm-4-837){ref-type="table-fn"}
  TNF-α × TL                --   0.47                                               0.39
  TNF-α × MWL               --   0.28                                               0.16
  TNF-α × TWL               --   0.52                                               0.33
  TNF-α × SPTI              --   0.30                                               −0.49
  TNF-α × SPTF              --   0.49                                               −0.03

**Notes:** Subjective perception of training intensity and volume (TL) in minutes, evaluated after court sessions (specific skills and physical capacities) and physical training (strength and jumping training). SPT evaluated initially (SPTI) and at the end (SPTF) of court sessions. Values are presented as mean ± standard error of the mean, *P* ≤ 0.05;

Significant correlation between variables.

**Abbreviations:** IL, interleukin; MWL, mean weekly load; SPT, subjective perception of tiredness; TL, total load; TNF, tumor necrosis factor; TWL, total weekly load; M1, pre-competitive period; M2, competitive I period; M3, competitive II period.

###### 

Pearson's correlations for URTI and training-load indicators

  Intervenient factors    M1   M2                                                M3
  ----------------------- ---- ------------------------------------------------- -------------------------------------------------
  Runny nose × TL         --   0.37                                              0.41
  Runny nose × MWL        --   0.36                                              0.18
  Runny nose × TWL        --   0.60[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.37
  Runny nose × SPTI       --   0.63[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.54
  Runny nose × SPTF       --   0.79[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.74[a](#tfn17-ijgm-4-837){ref-type="table-fn"}
  Cold × TL               --   0.36                                              −0.20
  Cold × MWL              --   0.18                                              0.20
  Cold × TWL              --   0.60[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.10
  Cold × SPTI             --   0.65[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.78[a](#tfn17-ijgm-4-837){ref-type="table-fn"}
  Cold × SPTF             --   0.79[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.85[a](#tfn17-ijgm-4-837){ref-type="table-fn"}
  Sore throat × TL        --   0.48                                              0.48
  Sore throat × MWL       --   0.26                                              0.52
  Sore throat × TWL       --   0.74[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.40
  Sore throat × SPTI      --   0.67[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.51
  Sore throat × SPTF      --   0.74[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.56
  Total symptoms × TL     --   0.56                                              0.26
  Total symptoms × MWL    --   0.27                                              0.46
  Total symptoms × TWL    --   0.78[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.36
  Total symptoms × SPTI   --   0.80[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.72[a](#tfn17-ijgm-4-837){ref-type="table-fn"}
  Total symptoms × SPTF   --   0.90[a](#tfn17-ijgm-4-837){ref-type="table-fn"}   0.86[a](#tfn17-ijgm-4-837){ref-type="table-fn"}

**Notes:** Subjective perception of training intensity and volume (TL) in minutes, evaluated after court sessions (specific skills and physical capacities) and physical training (strength and jumping training). SPT evaluated initially (SPTI) and at the end (SPTF) of court sessions. Values are presented as mean ± standard error of the mean, *P* ≤ 0.05;

Significant correlation between variables.

**Abbreviations:** IL, interleukin; MWL, mean weekly load; SPT, subjective perception of tiredness; TL, total load; TNF, tumor necrosis factor; TWL, total weekly load; M1, pre-competitive period; M2, competitive I period; M3, competitive II period; URTI, upper respiratory tract infection.
